How Atricure built a big business in Afib; A deep look into Abbott's new coronary imaging platform

This week, the DeviceTalks Weekly Podcasts delivers some learning. First, Dr. Nick West, CMO & divisional VP of global medical affairs at Abbott’s vascular business, discusses the European launch of the company's new coronary imaging platform. Dr. West explains how the AI-powered platform works and the benefits it offers for decision-making during coronary stenting procedures. He also delves into the AI-based technology behind the platform and the direction both imaging and medtech as a whole are heading with AI. Then, Mike Carrel, CEO and president of AtriCure, explains how the company became a force focusing on the atrial fibrillation (Afib) and left atrial appendage (LAA) markets. Carrel walks listeners through the company’s efforts to expand its reach into the connected pain management market. But then he makes a strong case building out its Afib pipeline which includes the EPi-Sense System, which in April received FDA approval to treat patients diagnosed with long-standing persistent atrial fibrillation. Sean Whooley, associate editor at MassDevice, delivers this week’s Newmarkers Newsmakers with updates from Google, Memic (SPAC ATTACK!), Medtronic, Teleflex, and Abbott.